Crescita Therapeutics Inc.
CTX.TO
TSX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -115.70K | -759.60K | -676.70K | -464.30K | -110.30K |
| Total Depreciation and Amortization | 260.70K | 228.80K | 222.20K | 285.60K | 278.60K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 44.30K | 93.80K | 62.10K | -57.10K | 137.50K |
| Change in Net Operating Assets | 793.70K | 747.80K | 792.20K | 516.20K | -497.60K |
| Cash from Operations | 983.00K | 310.90K | 399.70K | 280.40K | -191.80K |
| Capital Expenditure | -252.20K | -610.00K | -666.50K | -- | -77.20K |
| Sale of Property, Plant, and Equipment | 0.00 | 57.20K | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -252.20K | -552.80K | -666.50K | -- | -77.20K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -113.00K | -110.00K | -110.00K | -108.00K | -105.00K |
| Issuance of Common Stock | -- | -- | -- | -- | 0.00 |
| Repurchase of Common Stock | -77.00K | -117.00K | -48.00K | -78.00K | -153.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -50.00K | -- | -- | -50.00K | -- |
| Cash from Financing | -171.40K | -166.40K | -115.50K | -175.00K | -189.60K |
| Foreign Exchange rate Adjustments | 37.10K | -12.50K | 2.90K | 3.00K | -8.80K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 596.50K | -420.80K | -379.30K | 108.30K | -467.50K |